Biopharma

Elevation is latest biotech to face activist investor d...

Elevation Oncology has become the second biotech this week to face calls from an...

Big changes coming to federal health IT regulator?

In this edition of STAT's Health Tech newsletter: A draft of budget document sho...

Evotec axes 30% of assets as cost-cutting push hits pip...

Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30...

More proposed cuts to the NIH

And other critical biotech news stories, brought to you by The Readout.

Daiichi Sankyo celebrates its roots and blooming future...

The company, a host sponsor of this year's National Cherry Blossom Festival, tra...

A judge blocked the FDA’s plan to regulate lab develope...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is un...

CDC panel backs broader use of RSV shots

The committee endorsed lowering the age at which some people can receive RSV vac...

Ipsen's liver disease drug Iqirvo off to promising laun...

Ipsen’s Iqirvo is off to a solid start with sales of 23 million euros ($26 milli...

The latest news from Harvard Yard 

Plus more essential health news stories.

STAT+: Pharmalittle: We’re reading about Lilly’s weight...

Biotechs are being forced to push back clinical trials and drug testing in the w...

Sanofi pens $1.8B research deal for 2 bispecific antibo...

Sanofi is continuing to splash the cash for autoimmune and immunology assets thi...

STAT+: UnitedHealth cuts profit outlook by $3 billion a...

UnitedHealth cuts profits by $3 billion as more Medicare patients get care.

Eli Lilly’s new obesity pill lowers blood sugar and aid...

Promising late-stage trial results send shares up in pre-market trading

STAT+: Daily pill from Eli Lilly helps patients control...

A pill from Eli Lilly helped patients improve their blood sugar and shed weight,...

Opinion: Dismantling the one U.S. agency focused on old...

Splitting up the Administration for Community Living is antithetical to the syne...

Lilly's oral GLP-1 drug delivers Ozempic-like efficacy ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral G...

J&J calls time on Addex partnership 9 months after drop...

Nine months after Johnson & Johnson stepped back from an Addex Therapeutics-part...

Lilly’s oral GLP-1 drug delivers Ozempic-like efficacy ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral G...

For an Air Force vet, an FDA layoff brings back symptom...

For an Air Force veteran, an FDA layoff brings back symptoms of PTSD: "They say ...

Supreme Court to hear challenge to ACA rule requiring f...

The Supreme Court will hear a challenge of preventive health care coverage manda...

STAT+: To speed adoption of breast cancer AI, a radiolo...

National radiology network Radnet to acquire iCAD for over $100 million for its ...

Cellenkos Announces US FDA Orphan Drug Designation Gran...

HOUSTON, April 14, 2025 /PRNewswire/ -- Cellenkos Inc., a clinical-stage biotech...

STAT+: Trump budget draft proposes NIH consolidation an...

Draft Trump budget proposes a $20 billion NIH budget cut in 2026 and a sweeping ...

Neurelis Announces FDA Approval for Immediate Use Seizu...

San Diego, CA – April, 16, 2025 – Neurelis, Inc., today announced that the U.S. ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.